These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
691 related items for PubMed ID: 1019166
1. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM. Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166 [Abstract] [Full Text] [Related]
2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM. Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [Abstract] [Full Text] [Related]
3. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients]. Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y. Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833 [No Abstract] [Full Text] [Related]
5. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Mimran A, Shaldon S, Barjon P, Mion C. Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368 [Abstract] [Full Text] [Related]
6. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)]. Nigawara K, Yagihashi Y, Kogawa T, Kawamata A, Yamaya K, Sugawara S, Tulachan Y, Funyu T, Eba H, Kido K, Tanaka T, Morita S, Fukushi M, Furusawa M, Terayama Y, Hirayama N. Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404 [No Abstract] [Full Text] [Related]
7. Effect of saralasin on plasma aldosterone in hypertensive man. Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R. J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750 [No Abstract] [Full Text] [Related]
8. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension. Fagard R, Lijnen P, Amery A, Reybrouck T. Contrib Nephrol; 1978 Mar; 11():175-8. PubMed ID: 699588 [Abstract] [Full Text] [Related]
9. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects]. Beyer J, Liebau G, Steiner B, Schick K, Hayduk K. Verh Dtsch Ges Kreislaufforsch; 1977 Mar; 43():212-3. PubMed ID: 613577 [No Abstract] [Full Text] [Related]
11. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition? Davies DL, Beevers DG, Brown JJ, Cumming AM, Fraser R, Lever AF, Mason PA, Morton JJ, Robertson JI, Titterington M, Tree M. J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346 [No Abstract] [Full Text] [Related]
14. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion. Blair-West JR, Coghlan JP, Denton DA, Niall HD, Scoggins BA, Tregear GW. Prog Biochem Pharmacol; 1976 May; 12():53-62. PubMed ID: 1019170 [Abstract] [Full Text] [Related]
15. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery. Romero JC, Holmes DR, Strong CG. Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227 [Abstract] [Full Text] [Related]
16. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension]. Beckerhoff R, Vetter W, Furrer J, Tuma J, Zàruba K, Vetter H, Siegenthaler W. Schweiz Med Wochenschr; 1976 Dec 04; 106(49):1738-41. PubMed ID: 1013696 [Abstract] [Full Text] [Related]
17. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance. Brunner HR, Gavras H, Ribeiro AB, Posternak L. Prog Biochem Pharmacol; 1976 Dec 04; 12():145-62. PubMed ID: 1019161 [Abstract] [Full Text] [Related]
20. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. Linas SL, Miller PD, McDonald KM, Stables DP, Katz F, Weil R, Schrier RW. N Engl J Med; 1978 Jun 29; 298(26):1440-4. PubMed ID: 349389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]